The impact of comorbidities on costs, utilities and health-related quality of life among HIV patients in a clinical setting in Bogotá

Mark JM Van Duin, Rafael Conde, Ben Wijnen, Silvia MAA Evers, Javier L. Gonzalez-Rodriguez, Mark JG Govers, Mickaël Hiligsmann

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Background: This study aimed to assess the impact of comorbidities (CMs) on costs, utilities and health-related quality of life (HRQOL) among HIV patients in Colombia. Methods: A cross-sectional study was conducted among 138 HIV patients at an outpatient clinic in Bogotá to assess their costs, utilities (EQ5D-5L) and HRQOL (EQ-VAS). CMs and other covariates were gathered from patient records. Multiple regression models were conducted to assess the impact of CMs. Results: Of all patients, 72% experienced CMs; of these, half experienced ≥2 CMs (N = 49). CMs had a statistically significant impact on utilities when the EQ5D-5L (P = 0.022) was applied among patient with ≥2 CMs. No statistical significance was found for the impact of CMs on costs. Conclusion: This study suggests that having multiple CMs significantly influences utility, and CMs have some impact on HRQOL measured using the EQ-VAS but this effect is at the border of significance. No significant impact was observed on costs.

Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalExpert Review of Pharmacoeconomics and Outcomes Research
Volume17
Issue number03
DOIs
StatePublished - May 4 2017
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Health Policy
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'The impact of comorbidities on costs, utilities and health-related quality of life among HIV patients in a clinical setting in Bogotá'. Together they form a unique fingerprint.

Cite this